TTY Biopharm Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 05, 2022 at 06:44 pm
TTY Biopharm Company Limited reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 1,165.52 million compared to TWD 1,043.17 million a year ago. Revenue was TWD 1,165.52 million compared to TWD 1,043.17 million a year ago. Net income was TWD 284.16 million compared to TWD 31.88 million a year ago. Basic earnings per share from continuing operations was TWD 1.14 compared to TWD 0.13 a year ago. Diluted earnings per share from continuing operations was TWD 1.14 compared to TWD 0.13 a year ago.
For the six months, sales was TWD 2,202.63 million compared to TWD 2,007.23 million a year ago. Revenue was TWD 2,202.63 million compared to TWD 2,007.23 million a year ago. Net income was TWD 511.67 million compared to TWD 235.02 million a year ago. Basic earnings per share from continuing operations was TWD 2.06 compared to TWD 0.95 a year ago. Diluted earnings per share from continuing operations was TWD 2.06 compared to TWD 0.94 a year ago.